BMC Cancer · 2019 · 10 citations · 14 references
Veterinary MedicineDermatologyOncologyCancer GeneticsMolecular OncologyTumor PathologyGermline Cancer PredispositionHereditary Cancer SyndromesMalignant NeoplasmsMalignant TumorsMelanocytic TumorsSkin TumorsBap1 LossBap1 Tumor Predisposition SyndromeBrca1 InactivationGermline MutationsManagement Of High-risk PatientsMelanocytic Tumor SyndromesMelanoma HistopathologyPathogenic Germline Variants
BACKGROUND: BRCA1 associated-protein 1 (BAP1) tumor predisposition syndrome is associated with an increased risk for malignant mesotheliomas, uveal and cutaneous melanomas, renal cell carcinomas, and singular cutaneous lesions. The latter are referred to as BAP1-inactivated melanocytic tumors (BIMTs). When multiple BIMTs manifest, they are considered potential markers of germline BAP1 mutations. CASE PRESENTATION: Here, we report a novel pathogenic BAP1 germline variant in a family with a history of BIMTs, cutaneous melanomas, and mesotheliomas. We also describe singular pathological aspects of the patient's BIMT lesions and their correlation with dermoscopic and reflectance confocal microscopy findings. CONCLUSIONS: This knowledge is crucial for the recognition of BIMTs by dermatologists and pathologists, allowing the determination of appropriate management for high-risk patients, such as genetic investigations and screening for potentially aggressive tumors.
14
Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · Genetics in Medicine · 2015 · 32.2K citations · Full text
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text
Germline mutations in BAP1 predispose to melanocytic tumors
Thomas Wiesner, Anna C. Obenauf, Rajmohan Murali et al. · Nature Genetics · 2011 · 724 citations